Atlas Brown Inc. Sells 67 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Atlas Brown Inc. lowered its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 5.4% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,184 shares of the healthcare conglomerate’s stock after selling 67 shares during the quarter. Atlas Brown Inc.’s holdings in UnitedHealth Group were worth $620,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. NewSquare Capital LLC acquired a new stake in UnitedHealth Group during the 4th quarter worth about $25,000. Marshall & Sterling Wealth Advisors Inc. purchased a new stake in UnitedHealth Group in the fourth quarter valued at approximately $26,000. Hurley Capital LLC purchased a new position in UnitedHealth Group during the 4th quarter worth approximately $28,000. Aster Capital Management DIFC Ltd acquired a new stake in shares of UnitedHealth Group in the fourth quarter worth $30,000. Finally, Promus Capital LLC purchased a new stake in UnitedHealth Group in the fourth quarter valued at $32,000. 87.86% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on UNH. Robert W. Baird decreased their price objective on UnitedHealth Group from $510.00 to $356.00 and set an “outperform” rating for the company in a report on Wednesday, May 14th. Wolfe Research cut their target price on shares of UnitedHealth Group from $501.00 to $390.00 and set an “outperform” rating for the company in a report on Tuesday, May 20th. Wall Street Zen lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Saturday, May 24th. TD Securities reissued a “hold” rating and set a $308.00 target price (down from $520.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. Finally, KeyCorp reduced their price target on UnitedHealth Group from $575.00 to $450.00 and set an “overweight” rating for the company in a report on Wednesday, May 14th. One analyst has rated the stock with a sell rating, seven have issued a hold rating and seventeen have given a buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $441.87.

Insiders Place Their Bets

In other UnitedHealth Group news, Director Kristen Gil purchased 3,700 shares of the business’s stock in a transaction on Thursday, May 15th. The shares were bought at an average cost of $271.17 per share, for a total transaction of $1,003,329.00. Following the completion of the purchase, the director now directly owns 3,818 shares of the company’s stock, valued at approximately $1,035,327.06. This trade represents a 3,135.59% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Stephen J. Hemsley bought 86,700 shares of UnitedHealth Group stock in a transaction on Friday, May 16th. The shares were acquired at an average price of $288.57 per share, for a total transaction of $25,019,019.00. Following the completion of the acquisition, the chief executive officer now owns 679,493 shares in the company, valued at $196,081,295.01. This represents a 14.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders purchased a total of 109,408 shares of company stock valued at $31,607,768 over the last 90 days. 0.33% of the stock is owned by company insiders.

UnitedHealth Group Stock Up 1.0%

Shares of UNH opened at $301.08 on Friday. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 52-week low of $248.88 and a 52-week high of $630.73. The stock has a fifty day simple moving average of $430.87 and a two-hundred day simple moving average of $494.23. The company has a market capitalization of $273.12 billion, a PE ratio of 19.42, a price-to-earnings-growth ratio of 1.37 and a beta of 0.56.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). The firm had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same quarter in the prior year, the business earned $6.91 EPS. As a group, equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.